Effect of transcutaneous electrical acupoint stimulation at different frequencies on mild hypertension: A randomized controlled trial
Complementary Therapies in Medicine · 2024
DOI: 10.1016/j.ctim.2024.103103 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Complementary Therapies in Medicine, 2024. Verfasst von Ling-Hui Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Acupuncture-moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China. Hauptthemen laut MEDLINE: Acupuncture Points, Hypertension, Transcutaneous Electric Nerve Stimulation, Blood Pressure. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, Key Technologies Research and Development Program.
Abstract (Originalsprache)
BACKGROUND: Transcutaneous electrical acupoint stimulation (TEAS) may contribute to blood pressure (BP) control, but the evidence remains insufficient. Our objectives were to evaluate the impact of TEAS on hypertension and determine the optimal frequency. METHODS: A total of 120 hypertensive patients were randomly allocated to the TEAS-2Hz group, TEAS-10Hz group, or usual care control group in a 1:1:1 ratio. All patients were advised to continue their usual antihypertensive regimen. Additionally, patients in the TEAS groups received TEAS therapy 3 times per week for 4 weeks, with a 4-week follow-up. RESULTS: The primary outcome was the change in systolic BP (SBP) from baseline to week 4. Secondary outcomes included changes in diastolic BP (DBP), mean arterial pressure (MAP), heart rate (HR), heart rate variability (HRV), and 12-item health survey (SF-12) at different time points. Both TEAS groups showed reductions in SBP relative to control (TEAS-2Hz group vs. control, -4.70 mmHg [95 % CI, -7.00 to -2.40 mmHg]; P < 0.001; TEAS-10Hz group vs. control, -8.66 mmHg [95 % CI, -10.97 to -6.36 mmHg]; P < 0.001). TEAS-10Hz provided a significant decrease in SBP than TEAS-2Hz (-3.96 mmHg [95 % CI, -1.66 to -6.26 mmHg]; P< 0.001). TEAS groups also exhibited reductions in DBP, MAP, HR, LF/HF ratio(LF/HF), very low frequency (VLF), and normalized low frequency (LF norm), and an increase in normalized high frequency (HF norm) than control. No differences were observed among groups in low frequency (LF), high frequency (HF), total power (TP), very low frequency (VLF), and SF-12. CONCLUSION: TEAS might be a promising adjunctive therapy for hypertension, and the recommended frequency is 10 Hz, which should be confirmed in larger trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Acupuncture-moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China.
- School of Acupuncture-moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China; The Key Unit of State Administration of Traditional Chines Medicine, Evaluation of Characteristic Acupuncture Therapy,…
Förderung
- National Key Research and Development Program of China
- Key Technologies Research and Development Program
Zitieren
APA
Ma, L. H., Xiu, J. Y., Ma, L. X., Zhang, Q. Y., Wang, X. Y., Sun, T. Y., Qian, X., Chen, M. Y., & He, J. L. (2024). Effect of transcutaneous electrical acupoint stimulation at different frequencies on mild hypertension: A randomized controlled trial. Complementary Therapies in Medicine. https://doi.org/10.1016/j.ctim.2024.103103
Vancouver
Ma LH, Xiu JY, Ma LX, Zhang QY, Wang XY, Sun TY, et al. Effect of transcutaneous electrical acupoint stimulation at different frequencies on mild hypertension: A randomized controlled trial. Complementary Therapies in Medicine. 2024. doi:10.1016/j.ctim.2024.103103
BibTeX
@article{Ma2024,
author = {Ma, Ling-Hui and Xiu, Jing-Yun and Ma, Liang-Xiao and Zhang, Qin-Yong and Wang, Xiu-Yan and Sun, Tian-Yi and Qian, Xu and Chen, Meng-Yu and He, Jia-Ling},
title = {Effect of transcutaneous electrical acupoint stimulation at different frequencies on mild hypertension: A randomized controlled trial},
journal = {Complementary Therapies in Medicine},
year = {2024},
doi = {10.1016/j.ctim.2024.103103}
}
EUVIMED